APLIF (MC $65 M) Covid 19 Phase 3 results NEXT MONTH = 10 Bagger Potential

Discussion in 'Stock picks and trading strategies' started by DollarChamp, Feb 12, 2021.

  1. DollarChamp

    DollarChamp Member

    Very low valuation of $65 million ,well financed with $20 million and BIG milestones is aorund the corner with the Phase 3 readout of the Covid 19 program and potential approval of the drug in Canada both expected during THIS Quarter . They expect to submit 2 NDA´s during the year including the covid 19 treatment . This under radar stock has potential to run to $10 and even higher .STRONG BUY


    Market Cap $65 million
    Cash $20 million
    Price $1.03

    Presentation
    https://7343a5f0-1b48-4477-8577-969...d/3d295b_2468d721a70a45c0bfaf03f68b748c4c.pdf


    Adding to the COVID-19 treatment toolbox
    https://www.thechronicleherald.ca/m...ing-to-the-covid-19-treatment-toolbox-540087/


    APLIF: Phase 3 PRESECO Trial Readout in Late March 2021…
    https://finance.yahoo.com/news/aplif-phase-3-preseco-trial-130500968.html


    [​IMG]


    [​IMG]
     

Share This Page